This video demonstrates the activation of a mouse's peritoneal macrophages using intravenous immunoglobulin and bacterial lipopolysaccharide. The co-stimulation activates the peritoneal macrophages into anti-inflammatory macrophages possessing immune regulatory activity.
Protocol
All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board. 1. Challenging Mice in Vivo with intravenous immunoglobulin and lipopolysaccharide (IVIg+LPS) and Harvesting Peritoneal Macrophages Weigh each mouse. Calculate the volume of IVIg (100 mg/mL stock concentration) needed to provide a final dose of 2.5 g/kg body weight. Calculate the amount of LPS (100 μ…
Disclosures
The authors have nothing to disclose.
Materials
Iscove's modified Dulbecco's medium (IMDM)
Life technologies
12440053
Fetal Bovine Serum (FBS)
Life technologies
12483-020
Penicillin-streptomycin
Life technologies
15140148
1X red blood cell lysis buffer
eBioscience
Cell dissociation buffer
Life technologies
13150016
Enzyme-Free, Hanks's-based, EDTA
Lipopolysaccharide (LPS)
Sigma aldrich
L 4516
From E. coli 0127:B8
IVIg (Gammunex)
Grifols
Received from BC Children's Hospital, Transfusion Medicine
IVIg (Gammagard liquid)
Baxter Healthcare Corporation
Received from BC Children's Hospital, Transfusion Medicine
IVIg (Octagam)
Octapharma
Received from BC Children's Hospital, Transfusion Medicine